About us

About us

Menarini in Italy

Menarini, born in 1886, is located in Florence where there is the headquarter of the entire Group that together with a research center and a manufacturing site represents a strategic industrial centre for the Group: it was here that the first pharmaceutical formulation were manufactured on an industrial scale.  

Menarini is present with over the counter products and prescription drugs marketed in Italy by A. Menarini Industrie Farmaceutiche Riunite.

About us

Our Group


VISIT THE MENARINI GROUP WEBSITE


High quality therapeutics and diagnostics solutions for patients, ethics as our underlying principle, dedication to innovation and advancement, strong people centricity and environmental sustainability. These five pillars form the foundation of the Menarini Group, an Italian pharmaceutical company with 135 years of history. Founded in 1886 in Naples under the name of Farmacia Internazionale, in 1915 Menarini moved to Florence where the Group’s headquarters are still located today.

The Menarini Group is present in 140 countries around the world. Its companies span from Europe to Asia, to Africa and the Middle East, to Central America and to the United States where with the acquisition of Stemline Therapeutics, a NASDAQ-listed biopharmaceutical company, the company marked its entry into the US oncology market.

Thanks to the valuable contribution of over 17,000 employees, every year almost 600 million packs of drugs are produced at the Group's 18 manufacturing sites including a biotech plant for the manufacturing of monoclonal antibodies that also serves external clients. Our drugs are distributed across 6 continents for the treatment of pathologies in cardiology, pneumology, inflammation and gastroenterology.

Menarini invests in the future and guarantees drug availability in the present for the improvement of patient health and well-being.

In its 10 Research & Development centers, Menarini’s main focus is dedicated to therapeutic areas with unresolved pathologies, such as oncology and anti-infectives (AMR), where increasing treatment options is fundamental to helping those in need. The Group's pipeline concentrates on innovative drugs and technologies including both small molecule and biologics for hematologic and solid tumors for greater personalized solutions.

The Group has also invested in diagnostics to develop instruments with high speed and precision for diagnoses in various fields such as clinical chemistry, diabetes, immunology, hematology, histology and point-of-care. In addition, Menarini is developing advanced technologies for the analysis of rare tumor cells with single cell precision.

From research to manufacturing, from distribution to scientific information, Menarini's goal is to achieve excellence.


Quality comes first

Quality is the backbone of our company and drives any activity in development, production, distribution and pharmacovigilance, required that a medicinal product is safe, effective and acceptable to patients.

Read More



about_us_molecola





Our presence in Italy

Available positions

Menarini employees make all the difference, every day.
Discover the available positions at Menarini Italy!

Read More


 

Our values

Everyday we put our values into action. 4 values, which have given life to Menarini and have shaped its history.

Read More

Our values


Menarini Blog

  • Menarini4People
Menarini Portugal: We “Make a Wish”
Read More
  • Menarini Events
  • Menarini News
The countdown to the XXV International Fair Play – Menarini Award has started!
Read More

2020

Acquisition of Stemline establishes Menarini’s presence in the U.S. biopharmaceutical oncology market.

2019

The board of Directors has appointed Elcin Barker Ergun as CEO of Menarini Group.

2018

The Menarini Group has decided to entrust the Chairmanship of the company to Eric Cornut.

2016

CellSearch, pioneer in advanced technologies for cancer diagnostics

2013

Acquisition of Silicon Biosystems.

2011

Acquisition of the Invida Group consolidating Menarini's presence in the Asia Pacific markets.

2009

Lucia e Alberto Giovanni Aleotti leading Menarini.

2003

Opening of Menarini Biotech in Pomezia (Rome).

1992

Acquisition of Berlin-Chemie which opens up Central-East Europe markets to Menarini.

Since the 90s

Menarini has expended its international business rapidly.

1978

Opening of Menarini Research&Development Division.

1964

Alberto Aleotti is appointed Director General of “Farmaceutica Menarini” and Internationalisation is launched with “Laboratorios Menarini” in Barcelona.

1915

Menarini opens its Florence premises.

1886

The “Farmacia Internazionale Menarini” opens in Naples.

2021

This year we shall be celebrating the 135th anniversary of the founding of our company.

Responsibility

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts.

Read more